Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-10-16, Stock:ABBV, The news for the past five days is as follows:
2019-10-09: NEWS1: J&J Ordered by Philadelphia Jury to Pay $8B in Risperdal Case.NEWS2: Gilead (GILD) Files NDA for RA Candidate Filgotinib in Japan.NEWS3: AbbVie Announces New Data from its Dermatology Portfolio and Pipeline at the 28th European Academy of Dermatology and Venereology (EADV) Congress.
2019-10-10: NEWS1: Why This Biotech Stock Was Bullish Enough To Relicense Its Own Drugs.NEWS2: J&J (JNJ) to Start Q3 Earnings Season for Pharma Sector.NEWS3: Top Ranked Income Stocks to Buy for October 10th.NEWS4: The Daily Biotech Pulse: UCB To Buy Ra Pharma, Reata Reacquires Rights To Nrf2 Activators From AbbVie, BioNTech IPO.
2019-10-11: NEWS1: Here Are Two Biotech Stocks To Watch As Earnings Season Kicks Off.NEWS2: These battered biotech stocks are now buying opportunities as Elizabeth Warren climbs in the polls.NEWS3: Gilead Stock Is Up After Releasing Promising Drug Data.NEWS4: 3 Big Stock Charts for Friday: AbbVie, Chubb and Applied Materials.
2019-10-14: NEWS1: Biotech Stock Rockets 34% After Decision To Reacquire Its Drugs Pays Off.NEWS2: AbbVie (ABBV) Gains As Market Dips: What You Should Know.NEWS3: This is Why AbbVie (ABBV) is a Great Dividend Stock.
2019-10-15: NEWS1: Reata Successfully Completes Neuromuscular Disorder Study.NEWS2: Allergan (AGN) Shareholders Approve Acquisition by AbbVie.NEWS3: How A Recently Reacquired Drug Added $1.8 Billion To This Biotech's Value.NEWS4: AbbVie, Bristol-Myers Squibb Getting the Most From Workers.NEWS5: J&J (JNJ) Beats on Q3 Earnings as Sales Rise, Ups 2019 View.

Answer: Rise